Related Experiment Video
Updated: Jun 5, 2025

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Published on: January 3, 2025
Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of
Yoshitaka Adachi1, Seitaro Terakura2, Masahide Osaki3
1Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan. yadachi@umich.edu.
Abstract:
Chimeric antigen receptor (CAR) T cell is a promising therapy for cancer, but factors that enhance the efficacy of CAR T cell remain elusive. Here we perform a genome-wide CRISPR screening to probe genes that regulate the proliferation and survival of CAR T cells following repetitive antigen stimulations. We find that genetic ablation of CUL5, encoding a core element of the multi-protein E3 ubiquitin-protein ligase complex, cullin-RING ligase 5, enhances human CD19 CAR T cell expansion potential and effector functions, potentially via the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway. In this regard, CUL5 knockout CD19 CAR T cells show sustained STAT3 and STAT5 phosphorylation, as well as delayed phosphorylation and degradation of JAK1 and JAK3. In vivo, shRNA-mediated knockdown of CUL5 enhances CD19 CAR T treatment outcomes in tumor-bearing mice. Our findings thus imply that targeting CUL5 in the ubiquitin system may enhance CAR T cell effector functions to enhance immunotherapy efficacy.
Insights
Genetic ablation of CUL5 enhances chimeric antigen receptor (CAR) T cell therapy. Knocking out CUL5 improves CAR T cell expansion and effector functions, boosting cancer immunotherapy outcomes.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Chimeric antigen receptor (CAR) T cell therapy shows promise for cancer treatment.
- Identifying factors to enhance CAR T cell efficacy is crucial for improving patient outcomes.
Purpose of the Study:
- To identify genes regulating CAR T cell proliferation and survival using genome-wide CRISPR screening.
- To investigate the role of CUL5 in CAR T cell function and therapeutic potential.
Main Methods:
- Genome-wide CRISPR screening was employed to identify genes affecting CAR T cell function.
- CUL5 was genetically ablated in human CD19 CAR T cells.
- JAK/STAT pathway activation and protein degradation were analyzed.
- In vivo studies utilized shRNA-mediated knockdown of CUL5 in tumor-bearing mice.
Main Results:
- Genetic ablation of CUL5 significantly enhanced human CD19 CAR T cell expansion and effector functions.
- CUL5 knockout CAR T cells exhibited sustained STAT3 and STAT5 phosphorylation.
- Delayed phosphorylation and degradation of JAK1 and JAK3 were observed in CUL5-deficient CAR T cells.
- CUL5 knockdown in vivo improved CD19 CAR T treatment outcomes in mice.
Conclusions:
- Targeting CUL5 within the ubiquitin system can enhance CAR T cell effector functions.
- CUL5 modulation represents a potential strategy to improve the efficacy of CAR T cell immunotherapy for cancer treatment.
Related Concept Videos
The JAK-STAT Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Amplifying Signals via Enzymatic Cascade
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

